- RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
Fei Wang et al, 2016, Oncotarget CrossRef - Simvastatin enhances the radiosensitivity of p53‑deficient cells via inhibition of mouse double minute 2 homolog
Ji Lee et al, 2017, International Journal of Oncology CrossRef - A framework for identification of on- and off-target transcriptional responses to drug treatment
Yi Huang et al, 2019, Scientific Reports CrossRef - Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells
Kun Xia et al, 2018, Oncology Letters CrossRef - Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease
MOHAMMAD J. ALKHATATBEH et al, 2016, Experimental and Therapeutic Medicine CrossRef - Statins were not associated with hepatocellular carcinoma after controlling for time-varying confounders in patients with diabetes
Yi-Chun Yeh et al, 2022, Journal of Clinical Epidemiology CrossRef - Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
Xiao-Chen Feng et al, 2023, World Journal of Gastrointestinal Oncology CrossRef - Dysregulated cholesterol regulatory genes in hepatocellular carcinoma
Dan Cao et al, 2023, European Journal of Medical Research CrossRef - Regulatory effects of statins on Akt signaling for prevention of cancers
Fatemeh Sadat Hosseini et al, 2024, Cellular Signalling CrossRef - Protective role of microRNA‐374 against myocardial ischemia‐reperfusion injury in mice following thoracic epidural anesthesia by downregulating dystrobrevin alpha‐mediated Notch1 axis
Zheng Zhao et al, 2019, Journal of Cellular Physiology CrossRef - Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
Linyuan Xue et al, 2020, Frontiers in Oncology CrossRef - Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway
Mathias Woschek et al, 2016, Nutrition and Cancer CrossRef - Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
Navneet Kumar et al, 2021, Frontiers in Genetics CrossRef - Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
Jiao Feng et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef